Klotho Neurosciences, Inc.
KLTO
$1.54
$0.042.67%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 136.16% | 1,572.72% | 2,220.86% | 61.93% | 340.37% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 136.16% | 1,572.72% | 2,220.86% | 61.93% | 340.37% |
| Operating Income | -136.16% | -1,572.72% | -2,220.86% | -61.93% | -340.37% |
| Income Before Tax | -232.44% | -1,534.23% | -1,953.71% | -70.80% | -289.57% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -232.44% | -1,534.23% | -1,953.71% | -70.80% | -289.57% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -232.44% | -1,534.23% | -1,953.71% | -70.80% | -289.57% |
| EBIT | -136.16% | -1,572.72% | -2,220.86% | -61.93% | -340.37% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -82.88% | -803.57% | -1,766.32% | -64.57% | -22,100.00% |
| Normalized Basic EPS | -82.37% | -813.46% | -1,746.67% | -65.14% | -27,700.00% |
| EPS Diluted | -82.88% | -659.00% | -1,700.00% | -64.57% | -22,100.00% |
| Normalized Diluted EPS | -82.37% | -813.46% | -1,746.67% | -65.14% | -27,700.00% |
| Average Basic Shares Outstanding | 81.91% | 79.92% | 10.30% | 3.63% | -98.55% |
| Average Diluted Shares Outstanding | 81.91% | 79.92% | 10.30% | 3.63% | -98.55% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |